Mark H. Kalenian, M.D.
Allergy & Immunology Physician · Dothan, AL
Mark H. Kalenian, M.D. is an allergy & immunology physician with a practice address in Dothan, Alabama, and NPI 1972504397, issued on Aug 9, 2005. Check the license (Alabama AL16176, as entered in NPPES) on the Alabama Board of Medical Examiners; the Medicare figures below come from public CMS files.
- Name
- Mark H. Kalenian
- Credential
- M.D.
- Primary taxonomy
- Allergy & Immunology Physician 207K00000X
- License number
- AL16176 AL
Self-reported in NPPES; status is on the state search - Practice location
- 520 John D. Odom RD., Dothan, AL 36303
- Phone
- (334) 794-2718
- Enumerated
- Aug 9, 2005
- Record last updated
- Feb 1, 2013 (not updated in 13 years: call before relying on the address or phone)
- Fax
- (334) 671-1905
- Medicaid ID
- 051509093 AL
- Medicare enrollment
- Enrolled (PECOS I20081231000031); accepts Medicare assignment
- Medical or professional school
- Hahnemann University College Of Medicine, 1985
- Entity
- Type 1 · individual
8 nearest allergy & immunology physician records → All 27 in Alabama → Look up another NPI →
Verify Mark H. Kalenian in five checks
- 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
- 2LicenseActive license and public ordersAlabama Board of Medical Examiners
Search for license AL16176Check the board - 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
- 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
- 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
2.5 times the Medicare Part D claims of the average allergy & immunology physician in 2024
1,859 Medicare Part D claims for 298 beneficiaries, against an average of 741 among the 2,899 providers of this specialty who prescribed in Part D. Brand-name drugs were 20% of claims.
Most prescribed
- Fluticasone Propionate198 claims
- Azelastine Hcl185 claims
- Levocetirizine Dihydrochloride168 claims
- Montelukast Sodium156 claims
- Famotidine119 claims
- Hydroxyzine Hcl79 claims
Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.
Industry payments in 2024: $1,822.79
91 payments; by number, the most common kind was food and beverage; the largest payer was AstraZeneca Pharmaceuticals LP. The 2,496 providers of this specialty with any payment received $8,321.81 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.
Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.
Bills Medicare through one group practice
- Continuum Health Aic, IncDothan, AL
Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through) (data.cms.gov).
Mark H. Kalenian among 27 allergy & immunology physician records in Alabama
Mark H. Kalenian, M.D. is one of 27 allergy & immunology physician records with a practice address in Alabama. 85% of them appear in a Medicare file (Part D prescribing, MIPS, Open Payments or Medicare group billing); this one does. Its NPI, issued in 2005, is newer than 0% of them.
- NPI issued2005 · 0% of these records are older, 74% newer
- In a Medicare fileYes · 85% of these records are
- In the CMS Doctors and Clinicians fileYes · 74% of these records are
- Graduated1985 · median 1998 among the 20 with a school on file
- Record last updated2013 · 74% of these records were not updated in five years or more
Source: CMS NPPES, file of Aug 9, 2026, every record with primary taxonomy 207K00000X and a Alabama practice address; Medicare files: CMS Part D Prescribers 2024, MIPS 2023, Open Payments 2024, Doctors and Clinicians (data.cms.gov).
Allergy & Immunology Physician providers in Alabama
There are 27 allergy & immunology physician records in Alabama.
All 27 in Alabama → Every provider in Dothan → Allergy & Immunology Physician nationwide →
The 8 allergy & immunology physician records with the nearest ZIP codes
- Robert Grubbe, M.D.Oxford, AL 362031457346140
- David Frazer, M.D.Montgomery, AL 361111710089503
- David Frazer, M.DMontgomery, AL 361111730140617
- Margaret Jakes, M.DMontgomery, AL 361111154381598
- Harry Lee, M.D.,Montgomery, AL 361111225029259
- Karen Barker, M.D.Daphne, AL 365261629268263
- William Davidson, MDDaphne, AL 365261578583191
- Michael Gates, M.D.Mobile, AL 366081801054754
Common questions
What is Mark H. Kalenian, M.D.'s NPI number?
Mark H. Kalenian, M.D.'s National Provider Identifier (NPI) is 1972504397, issued on Aug 9, 2005. An NPI identifies a provider in billing; it is not a license.
Where is Mark H. Kalenian, M.D. located?
The NPPES record lists a practice address at 520 John D. Odom RD., Dothan, AL, 36303. Phone: (334) 794-2718. Providers update this record themselves, so call before visiting.
How can I verify Mark H. Kalenian, M.D.'s license?
NPPES lists Alabama license number AL16176, as entered by the provider. Search the Alabama Board of Medical Examiners at https://www.albme.gov/. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.
How much does Mark H. Kalenian, M.D. prescribe under Medicare Part D?
In 2024, Mark H. Kalenian, M.D. had 1,859 Medicare Part D claims for 298 beneficiaries; the average among allergy & immunology physician prescribers was 741. Part D covers Medicare prescriptions only.
Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.
Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.